HUT73779A - Method of combating acyclovir-resistant herpes simplex viral infections - Google Patents

Method of combating acyclovir-resistant herpes simplex viral infections Download PDF

Info

Publication number
HUT73779A
HUT73779A HU9503135A HU9503135A HUT73779A HU T73779 A HUT73779 A HU T73779A HU 9503135 A HU9503135 A HU 9503135A HU 9503135 A HU9503135 A HU 9503135A HU T73779 A HUT73779 A HU T73779A
Authority
HU
Hungary
Prior art keywords
carbamoyl
butyl
ethyl
cme
group
Prior art date
Application number
HU9503135A
Other languages
English (en)
Hungarian (hu)
Other versions
HU9503135D0 (en
Inventor
James Gus Chafouleas
Robert Deziel
Original Assignee
Bio Mega Boehringer Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bio Mega Boehringer Ingelheim filed Critical Bio Mega Boehringer Ingelheim
Publication of HU9503135D0 publication Critical patent/HU9503135D0/hu
Publication of HUT73779A publication Critical patent/HUT73779A/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HU9503135A 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections HUT73779A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA002095408A CA2095408A1 (en) 1993-05-03 1993-05-03 Method of combating acyclovir-resistant herpes simplex viral infections

Publications (2)

Publication Number Publication Date
HU9503135D0 HU9503135D0 (en) 1996-01-29
HUT73779A true HUT73779A (en) 1996-09-30

Family

ID=4151571

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9503135A HUT73779A (en) 1993-05-03 1994-04-29 Method of combating acyclovir-resistant herpes simplex viral infections

Country Status (13)

Country Link
EP (1) EP0767671A1 (no)
JP (1) JPH08509476A (no)
KR (1) KR960701651A (no)
CN (1) CN1126438A (no)
AU (1) AU683465B2 (no)
BR (1) BR9406575A (no)
CA (1) CA2095408A1 (no)
CZ (1) CZ287795A3 (no)
HU (1) HUT73779A (no)
NO (1) NO954390L (no)
SG (1) SG48806A1 (no)
SK (1) SK132695A3 (no)
WO (1) WO1994025046A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6599887B2 (en) 1988-07-07 2003-07-29 Chimerix, Inc. Methods of treating viral infections using antiviral liponucleotides
US5817638A (en) * 1988-07-07 1998-10-06 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
US6252060B1 (en) 1988-07-07 2001-06-26 Nexstar Pharmaceuticals, Inc. Antiviral liponucleosides: treatment of hepatitis B
CA2230750C (en) * 1994-12-28 2002-05-21 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes peptidomimetic compounds
CN109627243B (zh) * 2019-01-09 2021-06-29 广西壮族自治区水产科学研究院 一种喷昔洛韦-铜配合物、合成方法及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2033448C (en) * 1990-12-31 1996-11-26 Boehringer Ingelheim (Canada) Ltd./ Boehringer Ingelheim (Canada) Ltee Antiherpes compositions and method of use
EP0560267B1 (en) * 1992-03-12 1998-08-19 Boehringer Ingelheim (Canada) Ltd. Isosteric antiherpes peptide derivatives

Also Published As

Publication number Publication date
KR960701651A (ko) 1996-03-28
AU683465B2 (en) 1997-11-13
HU9503135D0 (en) 1996-01-29
BR9406575A (pt) 1996-03-19
JPH08509476A (ja) 1996-10-08
NO954390L (no) 1996-01-02
CN1126438A (zh) 1996-07-10
EP0767671A1 (en) 1997-04-16
WO1994025046A1 (en) 1994-11-10
CA2095408A1 (en) 1994-11-04
SG48806A1 (en) 1998-05-18
CZ287795A3 (en) 1996-06-12
SK132695A3 (en) 1996-10-02
AU6642394A (en) 1994-11-21
NO954390D0 (no) 1995-11-02

Similar Documents

Publication Publication Date Title
JP3209553B2 (ja) ヘルペス感染治療用医薬組成物
JP3209552B2 (ja) ヘルペス感染治療用医薬組成物
EP0560267B1 (en) Isosteric antiherpes peptide derivatives
HUT73779A (en) Method of combating acyclovir-resistant herpes simplex viral infections
EP0618226B1 (en) Inhibitors of herpes viral ribonculeotide reductase
US5574015A (en) Isosteric antiherpes peptide derivatives
EP0560274B1 (en) Antiherpes peptide derivatives having a ureido N-terminus
AU671825C (en) Isosteric antiherpes peptide derivatives
EP0837845B1 (en) Herpes ribonucleotide reductase inhibitors

Legal Events

Date Code Title Description
DGB9 Succession in title of applicant

Owner name: BOEHRINGER INGELHEIM (CANADA) LTD., CA

DFD9 Temporary protection cancelled due to non-payment of fee